Hirayama disease: Difference between revisions

From WikiMD's Medical Encyclopedia

CSV import
 
CSV import
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
Hirayama Disease
{{SI}}
Hirayama disease, also known as monomelic amyotrophy, is a rare neurological condition characterized by muscle weakness and atrophy in the upper limbs, particularly affecting young males. This condition is named after Dr. Keizo Hirayama, who first described it in 1959.
{{Infobox medical condition
== Clinical Features ==
| name            = Hirayama disease
Hirayama disease typically presents in the late teens or early twenties. The main clinical features include:
| image          = [[File:Cervical_spine_125153_rgbca_67m.png|left|thumb|Cervical spine MRI showing features of Hirayama disease]]
* '''[[Muscle Weakness and Atrophy]]''': Primarily affects the distal muscles of the hand and forearm, leading to a characteristic "oblique amyotrophy."
| caption        = MRI of the cervical spine in a patient with Hirayama disease
* '''[[Unilateral or Asymmetric Involvement]]''': Often affects one side more than the other.
| synonyms        = Monomelic amyotrophy, juvenile muscular atrophy of distal upper extremity
* '''[[Cold Sensitivity]]''': Symptoms may worsen in cold environments.
| specialty      = [[Neurology]]
* '''[[No Sensory Loss]]''': Unlike other neurological conditions, Hirayama disease does not typically involve sensory deficits.
| symptoms        = [[Muscle weakness]], [[muscle atrophy]] in the hand and forearm
| onset          = Adolescence or early adulthood
| duration        = Progressive over several years, then stabilizes
| causes          = [[Spinal cord]] compression due to forward displacement of the posterior dural sac
| risks          = Male gender, age 15-25
| diagnosis      = [[Magnetic resonance imaging|MRI]], clinical examination
| differential    = [[Amyotrophic lateral sclerosis]], [[spinal muscular atrophy]], [[cervical spondylotic myelopathy]]
| treatment      = [[Physical therapy]], [[cervical collar]], surgical intervention in severe cases
| prognosis      = Generally good, with stabilization of symptoms
| frequency      = Rare, more common in [[Asia]]
}}
== Hirayama Disease ==
[[File:Modern_3T_MRI.JPG|left|thumb|Modern 3T MRI machine used for diagnosing Hirayama disease]]
'''Hirayama disease''', also known as monomelic amyotrophy, is a rare neurological disorder characterized by muscle weakness and atrophy in the distal upper limbs. It predominantly affects young males and is considered a type of motor neuron disease.
== Pathophysiology ==
== Pathophysiology ==
The pathophysiology of Hirayama disease is not completely understood, but it is believed to involve a dynamic compression of the cervical spinal cord during neck flexion. This compression leads to ischemia and subsequent motor neuron damage in the anterior horn of the spinal cord.
Hirayama disease is believed to be caused by a dynamic compression of the cervical spinal cord during neck flexion. This compression leads to ischemia and subsequent damage to the anterior horn cells, which are responsible for innervating the muscles of the hand and forearm.
== Clinical Presentation ==
Patients with Hirayama disease typically present with insidious onset of unilateral or asymmetric weakness and atrophy of the hand and forearm muscles. The condition is often painless and progresses slowly over several years before stabilizing.
== Diagnosis ==
== Diagnosis ==
Diagnosis of Hirayama disease is primarily clinical, supported by imaging studies such as MRI. Key diagnostic features include:
The diagnosis of Hirayama disease is primarily clinical, supported by imaging studies. [[Magnetic resonance imaging|MRI]] of the cervical spine is crucial for diagnosis, as it can demonstrate the forward displacement of the posterior dural sac and the loss of attachment to the vertebral bodies during neck flexion.
* '''[[MRI Findings]]''': Flexion MRI of the cervical spine may show forward displacement of the posterior dural sac and flattening of the spinal cord.
* '''[[Electromyography (EMG)]]''': May show chronic denervation in the affected muscles.
== Treatment ==
== Treatment ==
There is no cure for Hirayama disease, but treatment focuses on managing symptoms and preventing progression. Options include:
There is no definitive cure for Hirayama disease. Management focuses on preventing further progression and alleviating symptoms. Patients are often advised to avoid neck flexion and may be fitted with a cervical collar. Physical therapy can help maintain muscle strength and function.
* '''[[Cervical Collar]]''': To prevent neck flexion and reduce spinal cord compression.
* '''[[Physical Therapy]]''': To maintain muscle strength and function.
* '''[[Surgical Intervention]]''': In some cases, surgery may be considered to stabilize the cervical spine.
== Prognosis ==
== Prognosis ==
The prognosis for Hirayama disease is generally favorable, with many patients experiencing stabilization of symptoms after a few years. However, some degree of muscle weakness and atrophy may persist.
The prognosis for Hirayama disease is generally favorable, with many patients experiencing stabilization of symptoms after a few years. However, some degree of muscle weakness and atrophy may persist.
== Epidemiology ==
== See also ==
Hirayama disease is more common in Asian populations, particularly in Japan and India. It predominantly affects males, with a male-to-female ratio of approximately 20:1.
* [[Motor neuron disease]]
== See Also ==
* [[Spinal cord]]
* [[Monomelic Amyotrophy]]
* [[Muscle atrophy]]
* [[Cervical Myelopathy]]
[[Category:Neurological disorders]]
* [[Motor Neuron Disease]]
* Hirayama, K. (1959). "Juvenile muscular atrophy of unilateral upper extremity (Hirayama disease)." *Neurology*.
* Misra, U. K., & Kalita, J. (2007). "Hirayama disease." *Journal of Neurology*.
{{rare diseases}}
[[Category:Neurology]]
[[Category:Rare diseases]]
[[Category:Spinal cord disorders]]

Latest revision as of 04:04, 7 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Hirayama disease
Cervical spine MRI showing features of Hirayama disease
Synonyms Monomelic amyotrophy, juvenile muscular atrophy of distal upper extremity
Pronounce N/A
Specialty Neurology
Symptoms Muscle weakness, muscle atrophy in the hand and forearm
Complications N/A
Onset Adolescence or early adulthood
Duration Progressive over several years, then stabilizes
Types N/A
Causes Spinal cord compression due to forward displacement of the posterior dural sac
Risks Male gender, age 15-25
Diagnosis MRI, clinical examination
Differential diagnosis Amyotrophic lateral sclerosis, spinal muscular atrophy, cervical spondylotic myelopathy
Prevention N/A
Treatment Physical therapy, cervical collar, surgical intervention in severe cases
Medication N/A
Prognosis Generally good, with stabilization of symptoms
Frequency Rare, more common in Asia
Deaths N/A


Hirayama Disease[edit]

Modern 3T MRI machine used for diagnosing Hirayama disease

Hirayama disease, also known as monomelic amyotrophy, is a rare neurological disorder characterized by muscle weakness and atrophy in the distal upper limbs. It predominantly affects young males and is considered a type of motor neuron disease.

Pathophysiology[edit]

Hirayama disease is believed to be caused by a dynamic compression of the cervical spinal cord during neck flexion. This compression leads to ischemia and subsequent damage to the anterior horn cells, which are responsible for innervating the muscles of the hand and forearm.

Clinical Presentation[edit]

Patients with Hirayama disease typically present with insidious onset of unilateral or asymmetric weakness and atrophy of the hand and forearm muscles. The condition is often painless and progresses slowly over several years before stabilizing.

Diagnosis[edit]

The diagnosis of Hirayama disease is primarily clinical, supported by imaging studies. MRI of the cervical spine is crucial for diagnosis, as it can demonstrate the forward displacement of the posterior dural sac and the loss of attachment to the vertebral bodies during neck flexion.

Treatment[edit]

There is no definitive cure for Hirayama disease. Management focuses on preventing further progression and alleviating symptoms. Patients are often advised to avoid neck flexion and may be fitted with a cervical collar. Physical therapy can help maintain muscle strength and function.

Prognosis[edit]

The prognosis for Hirayama disease is generally favorable, with many patients experiencing stabilization of symptoms after a few years. However, some degree of muscle weakness and atrophy may persist.

See also[edit]